SCHEMBL22026428

SCHEMBL22026428

CCN(CC(=O)NN)c1ccccc1

nearest known ligand 0.57

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ AOC3 Q16853 2/20 0.54
▸ MEN1 O00255 4/20 0.51
▸ KMT2A Q03164 4/20 0.51
▸ NPC1 O15118 1/20 0.51
▸ RAB9A P51151 1/20 0.51
▸ NOX1 Q9Y5S8 1/20 0.51
▸ L3MBTL1 Q9Y468 2/20 0.47
▸ ALDH1A1 P00352 3/20 0.47
▸ TSHR P16473 2/20 0.47
▸ GLA P06280 1/20 0.47
▸ CNR2 P34972 3/20 0.46
▸ CYP1A2 P05177 1/20 0.45
▸ CYP3A4 P08684 1/20 0.45
▸ CYP2D6 P10635 1/20 0.45
▸ CYP2C9 P11712 1/20 0.45
▸ CYP2C19 P33261 1/20 0.45
▸ RECQL P46063 1/20 0.45
▸ NPSR1 Q6W5P4 1/20 0.45
▸ MAPT P10636 2/20 0.43
▸ TDP1 Q9NUW8 2/20 0.43

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL11792163 0.85 L3MBTL1 (0.51) AOC3MEN1KMT2ANPC1RAB9A
SCHEMBL22025438 0.82 ALDH1A1 (0.65) AOC3MEN1KMT2AL3MBTL1ALDH1A1
SCHEMBL3141234 0.81 MEN1 (0.50) MEN1KMT2ANPC1RAB9ANOX1
SCHEMBL1132513 0.81 ALDH1A1 (0.53) MEN1KMT2ANPC1RAB9ANOX1
SCHEMBL22026433 0.80 L3MBTL1 (0.44) MEN1KMT2AL3MBTL1ALDH1A1TSHR
SCHEMBL11562585 0.79 ALDH1A1 (0.52) MEN1KMT2ANPC1RAB9ANOX1
Hydrochloric Acid SCHEMBL8226907 0.79 ALDH1A1 (0.52) MEN1KMT2ANPC1RAB9ANOX1
Diethylaniline SCHEMBL28333434 0.79 MEN1 (0.59) MEN1KMT2ANPC1RAB9ANOX1
SCHEMBL705309 0.79 MEN1 (0.51) MEN1KMT2ANPC1RAB9ANOX1
Hydrochloric Acid SCHEMBL27818171 0.77 MEN1 (0.50) MEN1KMT2ANPC1RAB9ANOX1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20210253518-A1 KINASE INHIBITOR NISSAN CHEMICAL CORPORATION (JP) 2021-08-19 — — US disclosed
US-20200165194-A1 ADDITIVE COMPOSITION FOR CULTURE MEDIUM, ADDITIVE COMPOUND FOR CULTURE MEDIUM, AND METHOD FOR CULTURE OF CELLS OR TISSUE USING SAME NISSAN CHEMICAL CORPORATION (JP) 2020-05-28 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20210253518-A1 KINASE INHIBITOR LATS2, LATS1, MAP3K6 AOC3 4719/4885MEN1 4360/4885KMT2A 2351/4885
US-20200165194-A1 ADDITIVE COMPOSITION FOR CULTURE MEDIUM, ADDITIVE COMPOUND FOR CULTURE MEDIUM, AND METHOD FOR CULTURE OF CELLS OR TISSUE USING SAME NEFM, FGF2, FGF1 AOC3 1819/4885MEN1 263/4885KMT2A 2745/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback